The next-generation sequencing informatics market size has grown rapidly in recent years. It will grow from $10.23 billion in 2025 to $11.96 billion in 2026 at a compound annual growth rate (CAGR) of 16.9%. The growth in the historic period can be attributed to rising demand for precision diagnostics, advancement of high-throughput sequencers, growth in genomic research initiatives, increasing awareness of personalized medicine, expansion of bioinformatics capabilities.
The next-generation sequencing informatics market size is expected to see rapid growth in the next few years. It will grow to $22.14 billion in 2030 at a compound annual growth rate (CAGR) of 16.6%. The growth in the forecast period can be attributed to technological advancements in ngs informatics software, adoption of cloud-based genomic platforms, increasing collaborations between biotech and pharma companies, growing prevalence of genetic disorders, integration of ai and machine learning in genomics analysis. Major trends in the forecast period include AI-driven genomic data analysis, cloud-based sequencing platforms, personalized medicine applications, automation in NGS workflows, integration of IoT in genomic research.
The growing adoption of personalized medicine is expected to drive the expansion of the next-generation sequencing (NGS) informatics market. Personalized medicine customizes treatment and prevention strategies based on an individual’s genetic profile, lifestyle, and environment. This approach has gained traction due to advancements in genomics, which allow for the precise identification of genetic variations and the development of personalized treatments. NGS informatics supports personalized medicine by enabling comprehensive analysis of genomic data, making it well-suited for precision healthcare and tailored treatment strategies. By identifying genetic variations and predicting disease risk, NGS informatics reduces diagnostic uncertainty, enhances clinical decision-making, and improves patient outcomes. For example, in February 2024, the Personalized Medicine Coalition reported that the U.S. Food and Drug Administration approved 26 new personalized medicines in 2023, a substantial increase from the 12 approved in 2022. This trend reflects the increasing adoption of personalized medicine and is fueling the growth of the NGS informatics market.
Leading companies in the NGS informatics market are focusing on developing advanced solutions, such as cloud-based platforms, to enhance scalability, data security, and streamline genomic workflows. Cloud-based platforms are digital infrastructures that allow researchers and clinicians to store, process, and analyze large amounts of sequencing data either remotely or within local institutional environments. For example, in March 2023, Illumina Inc., a U.S.-based biotechnology company, introduced Connected Insights, a cloud-based software designed for the tertiary analysis of clinical NGS data. This platform streamlines genomic data interpretation and reporting, integrates more than 45 third-party knowledge sources, and shortens turnaround times for clinical reports. It automates variant interpretation and report generation, reducing manual effort and standardizing workflows across various assay types, such as comprehensive genomic profiling (CGP), whole-exome sequencing (WES), and transcriptomic data.
In May 2025, GeneDx Inc., a U.S.-based biotechnology company, acquired Fabric Genomics Inc., a company specializing in NGS informatics. This acquisition strengthens GeneDx’s capabilities in AI-driven genomic interpretation and expands access to advanced NGS solutions. It also enhances the company's offerings in rare disease diagnostics, hereditary risk assessment, and precision medicine. Fabric Genomics’ expertise in next-generation sequencing informatics will support GeneDx’s efforts to advance genomic solutions and improve patient outcomes in the rapidly growing field of personalized medicine.
Major companies operating in the next-generation sequencing informatics market are DNAnexus Inc., SOPHiA GENETICS SA, DNASTAR Inc., Geneious Biomatters Ltd., CosmosID Inc., QIAGEN N.V., Seven Bridges Genomics Inc., PierianDx Inc., Fabric Genomics Inc., Golden Helix Inc., Partek Incorporated, Real Time Genomics Inc., Sentieon Inc., Roche NimbleGen Inc., Agilent Alissa Interpret, WuXi NextCODE Genomics, DNAVision SA, Genoox Ltd., Congenica Ltd., PierianDx Holdings, Bionano Genomics Inc.
North America was the largest region in the next-generation sequencing informatics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the next-generation sequencing informatics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the next-generation sequencing informatics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the next-generation sequencing informatics market by increasing costs for imported sequencing instruments, software, and bioinformatics services. The higher tariffs have slowed adoption in regions reliant on imports, particularly in Asia-Pacific and Europe, affecting research institutes and biotechnology companies. Segments like high-throughput sequencers and cloud-based platforms are most affected. However, tariffs have encouraged local manufacturing and service development, creating opportunities for regional providers to expand their market presence.
The next-generation sequencing informatics market research report is one of a series of new reports that provides next-generation sequencing informatics market statistics, including next-generation sequencing informatics industry global market size, regional shares, competitors with a next-generation sequencing informatics market share, detailed next-generation sequencing informatics market segments, market trends and opportunities, and any further data you may need to thrive in the next-generation sequencing informatics industry. This next-generation sequencing informatics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Next-generation sequencing (NGS) informatics refers to the use of computational tools and algorithms to process, analyze, and interpret large volumes of DNA or RNA sequencing data generated by next-generation sequencing technologies. Its primary objective is to efficiently identify genetic variations, mutations, and expression patterns, supporting applications in genomics research, personalized medicine, diagnostics, and drug development.
The main offerings of next-generation sequencing (NGS) informatics include software, platforms, and services. Software encompasses computer programs and bioinformatics tools designed to process, analyze, interpret, and visualize large-scale genomic data from NGS platforms. The offerings cover storage and computing solutions, commercial data analysis, interpretation and reporting tools, informatics services, and laboratory information management systems (LIMS), and can be deployed via cloud, on-premises, or hybrid systems. These informatics solutions are applied in research and development, clinical diagnostics, drug discovery, and agrigenomics, serving academic and research institutions, pharmaceutical and biotechnology companies, hospitals and clinical laboratories, and agricultural biotech organizations.
The next-generation sequencing informatics market includes revenues earned by entities through data analysis and interpretation, bioinformatics pipeline development, genomic data storage and management, variant annotation and prioritization, and reporting and visualization. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The next-generation sequencing informatics market size is expected to see rapid growth in the next few years. It will grow to $22.14 billion in 2030 at a compound annual growth rate (CAGR) of 16.6%. The growth in the forecast period can be attributed to technological advancements in ngs informatics software, adoption of cloud-based genomic platforms, increasing collaborations between biotech and pharma companies, growing prevalence of genetic disorders, integration of ai and machine learning in genomics analysis. Major trends in the forecast period include AI-driven genomic data analysis, cloud-based sequencing platforms, personalized medicine applications, automation in NGS workflows, integration of IoT in genomic research.
The growing adoption of personalized medicine is expected to drive the expansion of the next-generation sequencing (NGS) informatics market. Personalized medicine customizes treatment and prevention strategies based on an individual’s genetic profile, lifestyle, and environment. This approach has gained traction due to advancements in genomics, which allow for the precise identification of genetic variations and the development of personalized treatments. NGS informatics supports personalized medicine by enabling comprehensive analysis of genomic data, making it well-suited for precision healthcare and tailored treatment strategies. By identifying genetic variations and predicting disease risk, NGS informatics reduces diagnostic uncertainty, enhances clinical decision-making, and improves patient outcomes. For example, in February 2024, the Personalized Medicine Coalition reported that the U.S. Food and Drug Administration approved 26 new personalized medicines in 2023, a substantial increase from the 12 approved in 2022. This trend reflects the increasing adoption of personalized medicine and is fueling the growth of the NGS informatics market.
Leading companies in the NGS informatics market are focusing on developing advanced solutions, such as cloud-based platforms, to enhance scalability, data security, and streamline genomic workflows. Cloud-based platforms are digital infrastructures that allow researchers and clinicians to store, process, and analyze large amounts of sequencing data either remotely or within local institutional environments. For example, in March 2023, Illumina Inc., a U.S.-based biotechnology company, introduced Connected Insights, a cloud-based software designed for the tertiary analysis of clinical NGS data. This platform streamlines genomic data interpretation and reporting, integrates more than 45 third-party knowledge sources, and shortens turnaround times for clinical reports. It automates variant interpretation and report generation, reducing manual effort and standardizing workflows across various assay types, such as comprehensive genomic profiling (CGP), whole-exome sequencing (WES), and transcriptomic data.
In May 2025, GeneDx Inc., a U.S.-based biotechnology company, acquired Fabric Genomics Inc., a company specializing in NGS informatics. This acquisition strengthens GeneDx’s capabilities in AI-driven genomic interpretation and expands access to advanced NGS solutions. It also enhances the company's offerings in rare disease diagnostics, hereditary risk assessment, and precision medicine. Fabric Genomics’ expertise in next-generation sequencing informatics will support GeneDx’s efforts to advance genomic solutions and improve patient outcomes in the rapidly growing field of personalized medicine.
Major companies operating in the next-generation sequencing informatics market are DNAnexus Inc., SOPHiA GENETICS SA, DNASTAR Inc., Geneious Biomatters Ltd., CosmosID Inc., QIAGEN N.V., Seven Bridges Genomics Inc., PierianDx Inc., Fabric Genomics Inc., Golden Helix Inc., Partek Incorporated, Real Time Genomics Inc., Sentieon Inc., Roche NimbleGen Inc., Agilent Alissa Interpret, WuXi NextCODE Genomics, DNAVision SA, Genoox Ltd., Congenica Ltd., PierianDx Holdings, Bionano Genomics Inc.
North America was the largest region in the next-generation sequencing informatics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the next-generation sequencing informatics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the next-generation sequencing informatics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the next-generation sequencing informatics market by increasing costs for imported sequencing instruments, software, and bioinformatics services. The higher tariffs have slowed adoption in regions reliant on imports, particularly in Asia-Pacific and Europe, affecting research institutes and biotechnology companies. Segments like high-throughput sequencers and cloud-based platforms are most affected. However, tariffs have encouraged local manufacturing and service development, creating opportunities for regional providers to expand their market presence.
The next-generation sequencing informatics market research report is one of a series of new reports that provides next-generation sequencing informatics market statistics, including next-generation sequencing informatics industry global market size, regional shares, competitors with a next-generation sequencing informatics market share, detailed next-generation sequencing informatics market segments, market trends and opportunities, and any further data you may need to thrive in the next-generation sequencing informatics industry. This next-generation sequencing informatics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Next-generation sequencing (NGS) informatics refers to the use of computational tools and algorithms to process, analyze, and interpret large volumes of DNA or RNA sequencing data generated by next-generation sequencing technologies. Its primary objective is to efficiently identify genetic variations, mutations, and expression patterns, supporting applications in genomics research, personalized medicine, diagnostics, and drug development.
The main offerings of next-generation sequencing (NGS) informatics include software, platforms, and services. Software encompasses computer programs and bioinformatics tools designed to process, analyze, interpret, and visualize large-scale genomic data from NGS platforms. The offerings cover storage and computing solutions, commercial data analysis, interpretation and reporting tools, informatics services, and laboratory information management systems (LIMS), and can be deployed via cloud, on-premises, or hybrid systems. These informatics solutions are applied in research and development, clinical diagnostics, drug discovery, and agrigenomics, serving academic and research institutions, pharmaceutical and biotechnology companies, hospitals and clinical laboratories, and agricultural biotech organizations.
The next-generation sequencing informatics market includes revenues earned by entities through data analysis and interpretation, bioinformatics pipeline development, genomic data storage and management, variant annotation and prioritization, and reporting and visualization. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Next-Generation Sequencing Informatics Market Characteristics
3. Next-Generation Sequencing Informatics Market Supply Chain Analysis
4. Global Next-Generation Sequencing Informatics Market Trends and Strategies
5. Next-Generation Sequencing Informatics Market Analysis of End Use Industries
7. Global Next-Generation Sequencing Informatics Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Next-Generation Sequencing Informatics Total Addressable Market (TAM) Analysis for the Market
9. Next-Generation Sequencing Informatics Market Segmentation
10. Next-Generation Sequencing Informatics Market Regional and Country Analysis
11. Asia-Pacific Next-Generation Sequencing Informatics Market
12. China Next-Generation Sequencing Informatics Market
13. India Next-Generation Sequencing Informatics Market
14. Japan Next-Generation Sequencing Informatics Market
15. Australia Next-Generation Sequencing Informatics Market
16. Indonesia Next-Generation Sequencing Informatics Market
17. South Korea Next-Generation Sequencing Informatics Market
18. Taiwan Next-Generation Sequencing Informatics Market
19. South East Asia Next-Generation Sequencing Informatics Market
20. Western Europe Next-Generation Sequencing Informatics Market
21. UK Next-Generation Sequencing Informatics Market
22. Germany Next-Generation Sequencing Informatics Market
23. France Next-Generation Sequencing Informatics Market
24. Italy Next-Generation Sequencing Informatics Market
25. Spain Next-Generation Sequencing Informatics Market
26. Eastern Europe Next-Generation Sequencing Informatics Market
27. Russia Next-Generation Sequencing Informatics Market
28. North America Next-Generation Sequencing Informatics Market
29. USA Next-Generation Sequencing Informatics Market
30. Canada Next-Generation Sequencing Informatics Market
31. South America Next-Generation Sequencing Informatics Market
32. Brazil Next-Generation Sequencing Informatics Market
33. Middle East Next-Generation Sequencing Informatics Market
34. Africa Next-Generation Sequencing Informatics Market
36. Next-Generation Sequencing Informatics Market Competitive Landscape and Company Profiles
37. Next-Generation Sequencing Informatics Market Other Major and Innovative Companies
40. Next-Generation Sequencing Informatics Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Next-Generation Sequencing Informatics Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses next-generation sequencing informatics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for next-generation sequencing informatics? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The next-generation sequencing informatics market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Offering: Software; Platforms; Services2) By Product And Services: Storage And Computing Tools; Commercial Data Analysis; Data Interpretation And Reporting Tools; Informatics Services
3) By Deployment Mode: Cloud; On-Premise; Hybrid
4) By Application: Research And Development; Clinical Diagnostics; Drug Discovery; Agrigenomics
5) By End User: Academic And Research Institutes; Pharmaceutical And Biotechnology Companies; Hospitals And Clinical Laboratories; Agricultural Biotechnology Companies
Subsegments:
1) By Software: Data Analysis Software; Data Management And Storage Tools; Workflow Management Software; Sequence Alignment Tools; Variant Analysis Software; Clinical Interpretation Software2) By Platforms: On-Premises Platforms; Cloud-Based Platforms; Hybrid Platforms
3) By Services: Data Analysis Services; Consulting And Implementation Services; Data Management And Storage Services; Technical Support And Maintenance Services; Training And Education Services
Companies Mentioned: DNAnexus Inc.; SOPHiA GENETICS SA; DNASTAR Inc.; Geneious Biomatters Ltd.; CosmosID Inc.; QIAGEN N.V.; Seven Bridges Genomics Inc.; PierianDx Inc.; Fabric Genomics Inc.; Golden Helix Inc.; Partek Incorporated; Real Time Genomics Inc.; Sentieon Inc.; Roche NimbleGen Inc.; Agilent Alissa Interpret; WuXi NextCODE Genomics; DNAVision SA; Genoox Ltd.; Congenica Ltd.; PierianDx Holdings; Bionano Genomics Inc.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Next-Generation Sequencing Informatics market report include:- DNAnexus Inc.
- SOPHiA GENETICS SA
- DNASTAR Inc.
- Geneious Biomatters Ltd.
- CosmosID Inc.
- QIAGEN N.V.
- Seven Bridges Genomics Inc.
- PierianDx Inc.
- Fabric Genomics Inc.
- Golden Helix Inc.
- Partek Incorporated
- Real Time Genomics Inc.
- Sentieon Inc.
- Roche NimbleGen Inc.
- Agilent Alissa Interpret
- WuXi NextCODE Genomics
- DNAVision SA
- Genoox Ltd.
- Congenica Ltd.
- PierianDx Holdings
- Bionano Genomics Inc.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 11.96 Billion |
| Forecasted Market Value ( USD | $ 22.14 Billion |
| Compound Annual Growth Rate | 16.6% |
| Regions Covered | Global |
| No. of Companies Mentioned | 22 |
